Goldman Sachs’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8K | Buy |
+14,964
| New | +$35.8K | ﹤0.01% | 5009 |
|
|
2024
Q4 | – | Sell |
-1,414
| Closed | -$24K | – | 5193 |
|
|
2024
Q3 | $24K | Sell |
1,414
-13,017
| -90% | -$221K | ﹤0.01% | 4696 |
|
|
2024
Q2 | $218K | Buy |
14,431
+10,556
| +272% | +$159K | ﹤0.01% | 4330 |
|
|
2024
Q1 | $64.3K | Sell |
3,875
-2,604
| -40% | -$43.2K | ﹤0.01% | 4510 |
|
|
2023
Q4 | $104K | Buy |
6,479
+2,248
| +53% | +$36K | ﹤0.01% | 4457 |
|
|
2023
Q3 | $322K | Buy |
+4,231
| New | +$322K | ﹤0.01% | 4082 |
|